Crossref
Integrating in situ vaccination with checkpoint blockade therapy: a novel approach to enhance anti-tumour immunity in colorectal cancer
Biofunctional Materials · 2025
DOI: 10.55092/bm20250007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biofunctional Materials, 2025. Verfasst von Tolulope A. Owolabi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Owolabi, T. A., Adeyemi, S. A., Ngema, L. M., Penny, C., & Choonara, Y. E. (2025). Integrating in situ vaccination with checkpoint blockade therapy: a novel approach to enhance anti-tumour immunity in colorectal cancer. Biofunctional Materials. https://doi.org/10.55092/bm20250007
Vancouver
Owolabi TA, Adeyemi SA, Ngema LM, Penny C, Choonara YE. Integrating in situ vaccination with checkpoint blockade therapy: a novel approach to enhance anti-tumour immunity in colorectal cancer. Biofunctional Materials. 2025. doi:10.55092/bm20250007
BibTeX
@article{Owolabi2025,
author = {Owolabi, Tolulope A. and Adeyemi, Samson A. and Ngema, Lindokuhle M. and Penny, Clement and Choonara, Yahya E.},
title = {Integrating in situ vaccination with checkpoint blockade therapy: a novel approach to enhance anti-tumour immunity in colorectal cancer},
journal = {Biofunctional Materials},
year = {2025},
doi = {10.55092/bm20250007}
}
EUVIMED